Pacira BioSciences Files 8-K: Material Agreement & Financials
Ticker: PCRX · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, financials
Related Tickers: PCRX
TL;DR
Pacira BioSciences signed a material definitive agreement, filed 8-K with financials.
AI Summary
On April 7, 2025, Pacira BioSciences, Inc. filed an 8-K report detailing a material definitive agreement. The filing also included Regulation FD disclosures and financial statements/exhibits. The company, formerly known as Pacira Pharmaceuticals, Inc., is incorporated in Delaware and headquartered in Brisbane, California.
Why It Matters
This filing indicates a significant new agreement for Pacira BioSciences, which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's stock price.
Key Numbers
- 001-35060 — SEC File Number (Identifies the company's filing with the SEC)
- 51-0619477 — IRS Employer Identification No. (Tax identification for the company)
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- Pacira Pharmaceuticals, Inc. (company) — Former company name
- April 7, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Brisbane, California (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement filed by Pacira BioSciences?
The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
When was this 8-K report filed?
The report was filed on April 7, 2025.
What were Pacira BioSciences' former company names?
Pacira BioSciences, Inc. was formerly known as Pacira Pharmaceuticals, Inc., PACIRA INC, and Blue Acquisition Corp.
Where are Pacira BioSciences' principal executive offices located?
The principal executive offices are located at 2000 Sierra Point Parkway, Suite 900, Brisbane, California 94005.
What is the SIC code for Pacira BioSciences?
The Standard Industrial Classification (SIC) code for Pacira BioSciences is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding Pacira BioSciences, Inc. (PCRX).